Finvio Logo
Finvio

Complete TXMD Stock Valuation Analysis

Comprehensive intrinsic value analysis using 1 different methodologies

TXMD Peer Valuation Analysis

Relative valuation based on comparable company trading multiples

Peer Valuation Analysis

Fair Value Range Analysis

Based on median multiples from 9 peer companies in Healthcare

P/E Ratio
$-11.11
-1124.1%
Peer Median: 61.1x
EV/EBITDA
$0.00
-100.0%
Peer Median: 44.7x
P/S Ratio
$1.08
+0.0%
Peer Median: 8.7x
Interpretation: Each multiple provides a different perspective on fair value. Consider which multiple is most relevant for TXMD's business model and current situation.
Multiple Comparison
MultipleTXMD CurrentPeer MedianPeer AveragePremium/DiscountAssessment
P/E Ratio-6.0x61.1x61.1x-109.8%
Undervalued
EV/EBITDAInfinityx44.7x44.7xInfinity%
Overvalued
P/S Ratio8.7x8.7x9.4x0.0%
Fair Value
Peer Companies
Click any company to view their valuation
CompanyMarket CapP/E RatioEV/EBITDAP/S Ratio
$0.03B0.0x0.0x0.0x
$0.02B0.0x0.0x733.2x
$0.02B0.0x0.0x4.8x
$0.01B0.0x0.0x8.7x
$0.02B0.0x0.0x27.3x
$0.02B0.0x0.0x0.0x
$0.02B0.0x0.0x0.0x
$0.02B0.0x0.0x33.7x
$714.38B61.1x44.7x14.6x